News
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...
A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Scientists have discovered that earwax may hold clues to early Parkinson's detection. Analyzing volatile organic compounds ...
8d
ScienceAlert on MSNParkinson's Disease Might Not Start in The Brain, Study FindsParkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in ...
4d
MedPage Today on MSNCough Medicine Shows a Hint of Promise in Parkinson's DementiaAmbroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...
5d
News-Medical.Net on MSNClinical trial examines whether Ambroxol can slow dementia in people with Parkinson'sResearchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...
New research uncovers brain changes in Parkinson's disease. Feb 12, 2025. How the Parkinson's drug Levodopa causes psychiatric complications similar to drug abuse. Sep 11, 2024.
Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results